Scolaris Content Display Scolaris Content Display

بررسی روش‌های بستن لوله‌های رحمی در عقیم‌سازی زنان

Contraer todo Desplegar todo

Referencias

Aranda 1976 {published data only}

Aranda C, Broutin A, Edelman DA, Goldsmith A, Mangel T, Prada C, et al. A comparative study of electrocoagulation and tubal ring for tubal occlusion at laparoscopy. International Journal of Gynaecology and Obstetrics 1976;14:411‐5. CENTRAL

Aranda 1985 {published data only}

Aranda C, de Badia D, Mahran M, Feldblum PJ. A comparative clinical trial of the tubal ring versus the Rocket clip for female sterilisation. American Journal of Obstetrics and Gynecology 1985;153:755‐9. CENTRAL

Argueta 1980 {published data only}

Argueta G, Henriquez E, Amador MN, Gardner SD. Comparison of laparoscopic sterilisation via spring‐loaded clip and tubal ring. International Journal of Gynaecology and Obstetrics 1980;18:115‐8. CENTRAL

Dominik 2000 {published data only}

Dominik R, Gates D, Sokal D, Cordero M, Lasso de la Vega J, Remes Ruiz A, et al. Two randomized controlled trials comparing the Hulka and Filshie Clips for tubal sterilisation. Contraception 2000;62(4):169‐75. CENTRAL

Geirsson 1985 {published data only}

Geirsson RT, Currie J, Redpath A. Prospective comparison of postoperative morbidity after laparoscopic sterilisation with rings and clips. British Journal of Family Planning 1985;11:55‐9. CENTRAL

Gentile 2006 {published and unpublished data}

Gentile GP, Helbiga DW, Zacurb H, Park T, Lee YJ, Westhoff CL. Hormone levels before and after tubal sterilisation. Contraception 2006;73:507‐11. CENTRAL

Goynumer 2009 {published and unpublished data}

Goynumer G, Kayabasoglu F, Aydogdu S, Wetherilt L. The effect of tubal sterilisation through electrocoagulation on the ovarian reserve. Contraception 2009;80:90‐4. CENTRAL

Koetsawang 1978 {published data only}

Koetsawang S, Srisupandit S, Painter Cole L. Laparoscopic electrocoagulation and tubal ring techniques for sterilisation: a comparative study. International Journal of Gynaecology and Obstetrics 1978;15:455‐8. CENTRAL

Kohaut 2004 {published data only}

Kohaut BA, Musselman BL, Sanchez‐Ramos L, Kaunitz AM. Randomized trial to compare perioperative outcomes of Filshie clip vs.Pomeroy technique for postpartum and intraoperative cesarean tubal sterilisation: a pilot study. Contraception 2004;69:267‐70. CENTRAL

Pymar 2004 {published data only}

Pymar HC, Creinin MD, Vallejo MC. Prospective randomized, controlled study of postoperative pain after titanium silicone rubber clip or silastic ring tubal occlusion. Contraception 2004;69:145‐50. CENTRAL

Qui 2011 {published data only}

Qiu H, Li L, Wu S, Liang H, Yuan W, He Y. A comparative study of female sterilisation via modified Uchida and silver clip techniques in rural China. International Journal of Gynaecology and Obstetrics 2011;112(3):190‐4. CENTRAL

Rodriguez 2013 {published data only}

Rodriguez MI, Seuc A, Sokal DC. Comparative efficacy of postpartum sterilisation with the titanium clip versus partial salpingectomy: a randomised controlled trial. BJOG 2013;120(1):108‐12. CENTRAL

Siegle 2005 {published data only}

Siegle JC, Bishop LJ, Rayburn WF. Randomized comparison between two microlaparoscopic techniques for partial salpingectomy. JSLS: Journal of the Society of Laparoendoscopic Surgeons 2005;9(1):30‐4. CENTRAL

Sitompul 1984 {published data only}

Sitompul H, Lun KC, Lumbanraja M, Kaban RM, Albar E, Simanjuntak P, et al. Comparison of three types of tubal sterilisation: the Medan experience. Contraception 1984;29:55‐63. CENTRAL

Sokal 2000 {published data only}

Sokal D, Gates D, Amatya R, Dominik R. Two randomized controlled trials comparing the tubal ring and Filshie clip for tubal sterilisation. Fertility and Sterility 2000;74:525‐33. CENTRAL

Stovall 1991 {published data only}

Stovall TG, Ling FW, Henry GM, Ryan GM. Method failures of laparoscopic tubal sterilisation in a residency training program. Journal of Reproductive Medicine 1991;36:283‐6. CENTRAL

Toplis 1988 {published data only}

Toplis PJ, Newman MRB, Gillmer MDG, Tingey WR, Sellers S. Laparoscopic sterilisation ‐ a comparison of Hulka‐Clemens and Filshie clips. British Journal of Family Planning 1988;14:43‐5. CENTRAL

WHO 1982 {published data only}

WHO Task Force on Female Sterilization. Minilaparotomy or laparoscopy for sterilisation: a multicenter, multinational randomized study. American Journal of Obstetrics and Gynecology 1982;143:645‐52. CENTRAL

Yan 1990 {published data only}

Yan J‐S, Hsu J, Yin CS. Comparative study of Filshie clip and Pomeroy method for postpartum sterilisation. International Journal of Gynaecology and Obstetrics 1990;33:263‐7. CENTRAL

Alvarez 1989 {published data only}

Alvarez F, Faundes A, Brache V, Tejada AS, Segal S. Prospective study of the pituitary‐ovarian function after tubal sterilisation by Pomeroy or Uchida techniques. Fertility and Sterility 1989;51:604‐8. CENTRAL

Bordahl 1984 {published data only}

Bordahl PE, Bergsjo P, Solberg M. A controlled comparison of the Pomeroy resection technique and laparoscopic electrocoagulation of the tubes. Annales Chirugiae et Gynaecologiae 1984;73:288‐292. CENTRAL

Chapa 2015 {published data only}

Chapa HO, Venegas G. Vaginoscopy compared to traditional hysteroscopy for hysteroscopic sterilisation. A randomized trial. Journal of Reproductive Medicine 2015;60(1‐2):43‐7. CENTRAL

Dueholm 1986 {published data only}

Dueholm S, Zingenberg HJ, Sandgren G. Late sequelae following laparoscopic sterilisation employing electrocoagulation and tubal ring techniques: a comparative study. Annales Chirugiae et Gynaecologiae 1986;75:285‐289. CENTRAL

Lee 1991 {published data only}

Lee SH, Stephen Jones J. Postpartum tubal sterilisation. A comparative study of the Hulka clip and modified Pomeroy technique. Journal of Reproductive Medicine 1991;36:703‐6. CENTRAL

Lipscomb 1994 {published data only}

Lipscomb GH, Stovall TG, Summitt RL, Ling FW. Chromopertubation at laparoscopic tubal occlusion. Obstetrics and Gynecology 1994;83:725‐8. CENTRAL

Madrigal 1977 {published data only}

Madrigal V, Edelman DA, Henriquez E, Goldsmith A. A comparative study of spring‐loaded clips and electrocoagulation for female sterilisation. Journal of Reproductive Medicine 1977;18:41‐5. CENTRAL

Murray 1992 {published data only}

Murray JE, Hibbert ML, Heth SR, Letterie GS. A technique for laparoscopic Pomeroy tubal ligation with endoloop sutures. Obstetrics and Gynecology 1992;80:1053‐5. CENTRAL

Rivera 1989 {published data only}

Rivera R, Gaitan JR, Ruiz R, Hurley DP, Arenas M, Flores C, et al. Menstrual patterns and progesterone levels following different procedures of tubal occlusion. Contraception 1989;40:157‐67. CENTRAL

Sahwi 1989 {published data only}

Sahwi S, Toppozada SS, Kamel M, Anwar MY, Ismail AAA. Changes in menstrual blood after four methods of female tubal sterilisation. Contraception 1989;40:387‐98. CENTRAL

Agoestina 2003

Agoestina T. 8‐year follow‐up in a randomised trial of one vs two trans‐cervical insertions of quinacrine pellets for sterilisation in Indonesia. International Journal of Gynaecology and Obstetrics 2003;83(Suppl 2):S129‐31.

Arjona 2008

Arjona JE, Mino M, Cordon J, Povedano B, Pelegrin B, Castelo‐Branco C. Satisfaction and tolerance with office hysteroscopic tubal sterilisation. Fertility and Sterility 2008;90:1182‐6.

Bayer 2015

Bayer. Essure: what is Essure?. www.essure.com/what‐is‐essure Accessed 14 July 2015.

Bhattacharyya 2003

Bhattacharyya S. Quinicrine sterilisation (QS): the ethical issues. International Journal of Gynaecology and Obstetrics 2003;83(Suppl 2):S13‐21.

Bhiwandiwala 1980

Bhiwandiwala PP, Mumford SD, Feldblum PJ. A comparison of different laparoscopic techniques in 24439 procedures. American Journal of Obstetrics and Gynecology 1982;144:319‐31.

Blumenthal 2011

Blumenthal PD, Voedisch A, Gemzell‐Danielsson K. Strategies to prevent unintended pregnancy: increasing use of long‐acting reversible contraception. Human Reproduction Update 2011;17(1):121‐37.

Chi 1994

Chi IC. Use of multiple clips for tubal occlusion in interval laparoscopic sterilisation: circumstances and consequences. Contraception 1994;50:409‐16.

Chudnoff 2015

Chudnoff SG, Nichols JE, Levie M. Hysteroscopic Essure inserts for permanent contraception‐extended follow‐up results of a phase III, multicenter, international study. Journal of Minimally Invasive Gynecology 2015;Epub:[Epub ahead of print]. [DOI: 10.1016/j.jmig.2015.04.017]

Cleary 2013

Cleary TP, Tepper NK, Cwiak C, Whiteman MK, Jamieson DJ, Marchbanks PA, et al. Pregnancies after hysteroscopic sterilisation: a systematic review. Contraception 2013;87(5):539‐48.

Connor 2009

Connor VF. Essure: a review six years later. Journal of Minimally Invasive Gynecology 2009;16(3):282‐90.

Cooper 2003

Cooper JM, Carignan CS, Cher D, Kerin JF. Microinsert non incisional hysteroscopic sterilisation. Obstetrics and Gynecology 2003;102:59‐67.

Cooper 2010

Cooper NA, Smith P, Khan KS, Clark TJ. Vaginoscopic approach to outpatient hysteroscopy: a systematic review of the effect on pain. British Journal of Obstetrics and Gynaecology 2010;117(5):532‐9.

Duffy 2005

Duffy S, Marsh F. Female sterilisation: a cohort controlled comparative study of ESSURE versus laparoscopic sterilisation. BJOG 2005;112(11):1522‐8.

Fernandez 2014

Fernandez H, Legendre G, Blein C, Lamarsalle L, Panel P. Tubal sterilisation: pregnancy rates after hysteroscopic versus laparoscopic sterilisation in France, 2006‐2010. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2014;180:133‐7.

French 2004

French R, Van Vliet H, Cowan F, Mansour D, Morris S, Hughes D, et al. Progestogen‐releasing intrauterine systems versus other forms of reversible contraceptives for contraception. Cochrane Database of Systematic Reviews 2004, Issue 3. [DOI: 10.1002/14651858.CD001776.pub2]

Gariepy 2014

Gariepy AM, Creinin MD, Smith KJ, Xu X. Probablility of pregnancy after sterilisation: a comparison of hysteroscopic versus laparoscopic sterilisation. Contraception 2014;90(2):174‐81.

GRADE 2014 [Computer program]

McMaster University. GRADEpro. [Computer program on www.gradepro.org]. Version 2014. McMaster University, 2014.

Gupta 1980

Gupta I, Rodrigues S, Jain S, Gupta AN, Devi PK. Comparative morbidity following tubal fulguration by abdominal and vaginal routes. Indian Journal of Medicine 1980;72:231‐5.

Harrison 2014

Harrison MS, DiNapoli MN, Westhoff CL. Reducing postoperative pain after tubal ligation with rings or clips: a systematic review and meta‐analysis. Obstetrics and Gynecology 2014;124(1):68‐75.

Hillis 1999

Hillis SD, Marchbanks PA, Tylor LR, Peterson HB for the US Collaborative Review of Sterilization Working Group. Poststerilisation regret: findings from the United States Collaborative Review of Sterilization. Obstetrics and Gynecology 1999;93:889‐95.

IJOG 2003

No authors listed. Quinacrine sterilisation (QS): reports on 40,252 cases. International Journal of Gynaecology and Obstetrics 2003;83(Suppl 2):S1‐148.

Kaplan 1990

Kaplan P, Freund R, Squires J, Herz M. Control of immediate postoperative pain with topical bupivacaine hydrochloride for laparoscopic Falope ring tubal ligation. Obstetrics and Gynecology 1990;76:798‐802.

Kessel 1976

Kessel E, Pachauri S, McCann MF. A comparison of laparoscopic tubal occlusion by cautery, spring‐loaded clip and tubal ring. In: Advances in Female Sterilization Techniques. Hagerstown, MD: Harper & Row, c1976, 1976:69‐90.

Kraemer 2009

Kraemer DF, Yend P, Nicholse M. An economic comparison of female sterilisation of hysteroscopic tubal occlusion with laparoscopic bilateral tubal ligation. Contraception 2009;80:254‐60.

Kulier 2004

Kulier R, Boulvain M, Walker DM, De Candolle G, Campana A. Minilaparotomy and endoscopic techniques for tubal sterilisation. Cochrane Database of Systematic Reviews 2004, Issue 3. [DOI: 10.1002/14651858.CD001328.pub2]

la Chapelle 2015

la Chapelle CF, Veersema S, Brölmann HA, Jansen FW. Effectiveness and feasibility of hysteroscopic sterilisation techniques: a systematic review and meta‐analysis. Fertility and Sterility 2015;103(6):1516‐25.

Lippes 2015

Lippes J. Quinacrine sterilisation (QS): time for reconsideration. Contraception 2015;92(2):91‐5. [DOI: 10.1016/j.contraception.2015.06.005]

Lipscomb 1992

Lipscomb GH, Stovall TG, Ramanathan JA, Ling FW. Comparison of Silastic rings and electrocoagulation for laparoscopic tubal ligation under local anaesthesia. Obstetrics and Gynecology 1992;80:645‐9.

Lu 2003

Lu W, Zhu J, Zhong C, Zhao Y. A comparison of quinacrine sterilisation and surgical sterilisation (QS) in 600 women in Ghizhou province, China. International Journal of Gynaecology and Obstetrics 2003;83(Suppl 2):S51‐8.

Lumbiganon 2015

Lumbiganon P, Werawatakul Y, Laopaiboon M, Sothornwit J. Interventions for intra‐operative pain relief during postpartum mini‐laparotomy tubal ligation. Cochrane Database of Systematic Reviews 2015, Issue 7. [DOI: 10.1002/14651858.CD011807]

Mino 2007

Minö M, Arjona J, Cordón J, Pelegrin B, Povedano B, Chacon E. Success rate and patient satisfaction with the EssureTM sterilisation in an outpatient setting: a prospective study of 857 women. British Journal of Obstetrics and Gynaecology 2007;114:763‐6.

Ouzounelli 2015

Ouzounelli M, Reaven NL. Essure hysteroscopic sterilisation versus interval laparoscopic bilateral tubal ligation: a comparative effectiveness review. Journal of Minimally Invasive Gynecology 2015;22(3):342‐52.

Panel 2010

Panel P, Grosdemouge I. Predictive factors of Essure implant placement failure: prospective, multicenter study of 495 patients. Fertility and Sterility 2010;93(1):29‐34.

Peterson 1996

Peterson HB, Zhisen X, Hughes JM, Wilcox LS, Tylor LR, Trussel J for the US Collaborative Review of Sterilization Working Group. The risk of pregnancy after tubal sterilisation: findings from the US Collaborative Review of Sterilization. American Journal of Obstetrics and Gynecology 1996;174:1161‐70.

Peterson 2008

Peterson HB. Sterilization. Obstetrics and Gynecology 2008;111(1):189‐203.

RevMan 2014 [Computer program]

The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

Savage 2009

Savage UK, Masters SJ, Smid MC, Hung Y, Jacobson GF. Hysteroscopic sterilisation in a large group practice: experience and effectiveness. Obstetrics and Gynecology 2009;114(6):1227‐31.

Shavell 2009

Shavell VI, Abdallah ME, Diamond MP, Berman JM. Placement of a permanent birth control device at a university medical centre. Journal of Reproductive Medicine 2009;54:218‐22.

Sinha 2007

Sinha D, Kalathy V, Gupta JK, Clark TJ. The feasibility, success and patient satisfaction associated with outpatient hysteroscopic sterilisation. British Journal of Obstetrics and Gynaecology 2007;114:676‐83.

Sokal 2010a

Sokal DC, Trujillo V, Guzman SC, Guzman‐Serani R, Wheeless A, Hubacher D. Cancer risk after sterilisation with transcervical quinacrine: updated findings from a Chilean cohort. Contraception 2010;81(1):75‐8.

Sokal 2010b

Sokal DC, Vach TH, Nanda K, Mccann MF, Weiner DH, Drobnes C, et al. Quinacrine sterilisation and gynecologic cancers: a case‐control study in northern Vietnam. Epidemiology 2010;21(2):164‐71.

Soroodi‐Moghaddam 2003

Soroodi‐Moghaddam S. Quinacrine sterilisation (QS) in Iran and the use of HSG as a measure of success. International Journal of Gynaecology and Obstetrics 2003;83(Supp 2):S93‐6.

Suhadi 1998

Suhadi A, Anwar M, Soejoenoes A. Four year clinical evaluation of quinacrine pellets for non‐surgical female sterilisation. Advances in Contraception 1998;14:69‐77.

Suhadi 2003

Suhadi A, Anwar M, Soejoenoes A. 10‐year follow up of women who elected quinacrine sterilisation (QS) in Wonosobo, Central Java, Indonesia. International Journal of Gynaecology and Obstetrics 2003;83(Suppl 2):S137‐9.

Thiel 2014

Thiel J, Rattray D, Cher DJ. Pre‐hysterectomy assessment of immediate tubal occlusion with the third‐generation ESSURE insert (ESS505). Journal of Minimally Invasive Gynecology 2014;21(6):1055‐60.

UN 2013

United Nations, Department of Economic and Social Affairs, Population Division. World Contraceptive Patterns 2013. http://www.un.org/en/development/desa/population/publications/pdf/family/worldContraceptivePatternsWallChart2013.pdf2013:Accessed 14/07/2015.

Valle 2001

Valle RF, Carignan CS, Wright TC. Tissue response to the STOP microcoil transcervical permanent contraceptive device: results from a prehysterectomy study. Fertility and Sterility 2001;76:974‐80.

Veersema 2015

Veersema S. Hysteroscopy and contraception. Best Practice & Research. Clinical Obstetrics & Gynaecology 2015;Epub:[Epub ahead of print]. [DOI: <10.1016/j.bpobgyn.2015.03.013]

Lawrie 2011

Lawrie T, Nardin JM, Kulier R, Boulvain M. Techniques for the interruption of tubal patency for female sterilisation. Cochrane Database of Systematic Reviews 2011, Issue 2. [DOI: 10.1002/14651858.CD003034.pub2]

Nardin 2002

Nardin JM, Kulier R, Boulvain M, Peterson HB. Techniques for the interruption of tubal patency for female sterilisation. Cochrane Database of Systematic Reviews 2002, Issue 4. [DOI: 10.1002/14651858.CD003034.pub2]

Nardin 2003

Nardin JM, Kulier R, Boulvain M. Techniques for the interruption of tubal patency for female sterilisation. Cochrane Database of Systematic Reviews 2003, Issue 1. [DOI: 10.1002/14651858.CD003034.pub2]

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Aranda 1976

Methods

Randomisation not specified. Concealment of allocation by sealed envelopes containing a card that specified the technique for tubal occlusion

Participants

299 women requesting sterilisation for family planning reasons, at least 6 weeks postpartum
Conducted at the Hospital Mexico, San Jose, Costa Rica

Interventions

Electrocoagulation versus tubal ring, all laparoscopy. All under local anaesthesia and intravenous sedation

Outcomes

Surgical and early postoperative complications and complaints

Notes

Blinding of postoperative evaluation

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

"randomly assigned"

Allocation concealment (selection bias)

Unclear risk

Concealment of allocation by sealed envelopes containing a card which specified the technique of tubal occlusion. Assessed as a 'B' study (unclear allocation concealment) in original review

Blinding (performance bias and detection bias)
All outcomes

Low risk

Outcome assessor was blinded

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Selective reporting (reporting bias)

Unclear risk

Unable to determine

Other bias

Low risk

Women had similar socio‐demographic characteristics

Aranda 1985

Methods

Multicenter study. Randomisation by computer‐generated labels. Concealment of allocation by sealed opaque envelopes. Not stated whether sequentially numbered

Participants

663 women requesting sterilisation to limit family size and free of major systemic and pelvic abnormalities. Interval (55%) and postspontaneous abortion (45%). Conducted in San Jose, San Salvador and Cairo

Interventions

Tubal ring versus Rocket clip via minilaparotomy. Under general anaesthesia (55%) or local anaesthesia and intravenous sedation

Outcomes

Major and minor morbidity, technical failures and difficulties, failure rates and complaints

Notes

Blinding of postoperative evaluation. About 90% of women in both groups remained hospitalised for at least 1 night. The operations were performed with general anaesthesia in 55% of cases and with analgesia and/or sedation plus local anaesthesia in 45% of procedures

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Randomisation by computer‐generated labels

Allocation concealment (selection bias)

Unclear risk

Concealment of allocation by sealed opaque envelopes. Not stated if sequentially numbered. Assessed as a 'B' study (unclear allocation concealment) in original review

Blinding (performance bias and detection bias)
All outcomes

Low risk

Blinding of postoperative evaluation

Incomplete outcome data (attrition bias)
All outcomes

High risk

30 cases of technical failure (5% of total) were excluded from the analyses

Selective reporting (reporting bias)

Unclear risk

Other bias

Unclear risk

Argueta 1980

Methods

RCT

Participants

299 women requesting sterilisation at the Asociacion Demografica Salvadorena, San Salvador

Interventions

Spring‐loaded clip versus tubal ring all laparoscopy. All under local anaesthesia and intravenous sedation

Outcomes

Operative morbidity, technical failures and difficulties, failure rates, complaints

Notes

Participant and postoperative evaluation blinding

1 surgeon performed all surgical procedures on an outpatient basis

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Method of randomisation not specified

Allocation concealment (selection bias)

Unclear risk

Assessed as a 'B' study (unclear allocation concealment) in original review

Blinding (performance bias and detection bias)
All outcomes

Low risk

Participants and postoperative evaluators were blinded

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

In the clip group 54 women (36%) and 60 (40%) in the ring group were lost to follow‐up at 24 months

Selective reporting (reporting bias)

Unclear risk

Unable to determine

Other bias

Low risk

Women had similar socio‐demographic characteristics

Dominik 2000

Methods

2 multicentre RCTs conducted by Family Health International in Malaysia, Panama, Dominican Republic, Mexico, Venezuela, Guatamala, Haiti. 1 RCT involved a minilaparotomy approach, the other involved a laparoscopic approach

Participants

2126 women were included if they were at least 21 years old, had no pregnancy within 42 days, and no chronic medical conditions

878 participants were enrolled in the minilap study and 1248 enrolled in the laparoscopy study

Interventions

Filshie clip (1066 women) vs Hulka clip (1060 women)

Outcomes

Failure rates, technical failure and difficulties, morbidity

Assessed at 1, 6, and 12 months after sterilisation. A subset of women were assessed at 24 months

Notes

Article reports the combined results of 2 RCTs, 1 of sterilisation via minilaparotomy, the other by laparoscopy

Surgeons were experienced. Cumulative failure rates were 11.7 for Filshie and 28.1 per 1000 for Hulka at 24 months

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"computer‐generated randomisation scheme"

Allocation concealment (selection bias)

Low risk

Sealed sequentially numbered opaque envelope opened at the time of surgery

Blinding (performance bias and detection bias)
All outcomes

Low risk

Outcome assessor was blinded

Incomplete outcome data (attrition bias)
All outcomes

High risk

Loss to follow‐up at 12 months was high (31% and 34% for the laparoscopy and minilaparotomy studies, respectively) but balanced across the groups. Loss to follow‐up at 24 months in a subset of participants was 43%. Protocol deviations were low

Selective reporting (reporting bias)

Unclear risk

Not able to determine. ITT and per protocol analyses performed

Other bias

Low risk

Baseline characteristics were similar. Mean age was 31 years and average parity was 4.2 children

Geirsson 1985

Methods

RCT conducted in Scotland

Participants

79 women requesting sterilisation; excluded if postpartum or postabortion

Interventions

Falope rings (36 women) vs Filshie clips (34 women)

Outcomes

Day 1‐6 postoperative pain, analgesic requirements, additional medical assistance

Notes

Interval sterilisation via laparoscopy

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

"a prospective randomized comparison"

Allocation concealment (selection bias)

Unclear risk

Not described

Blinding (performance bias and detection bias)
All outcomes

Unclear risk

Not described

Incomplete outcome data (attrition bias)
All outcomes

High risk

9 post‐procedure exclusions due to intra‐operative difficulties, subsequent UTI, incomplete follow‐up and anaesthetic complications. Protocol deviations and ITT analysis not described

Selective reporting (reporting bias)

Unclear risk

Unable to determine

Other bias

High risk

Post‐randomisation exclusions of women with complications occurred in this study of morbidity

Gentile 2006

Methods

RCT

Participants

118 women requesting sterilisation

Interventions

62 Hulka clips and 56 electrocautery

Outcomes

Urinary and serum oestradiol and progesterone levels; participants' satisfaction and regret

Notes

Secondary outcomes relating to women’s satisfaction/regret have never been published. The authors were contacted and provided some additional information regarding method of randomisation/allocation concealment but were unable to find the unpublished data regarding women's satisfaction. Included but no pertinent outcome data available

Anaesthesia not specified

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Random number table

Allocation concealment (selection bias)

Low risk

Consecutively numbered sealed opaque envelopes (unpublished information)

Blinding (performance bias and detection bias)
All outcomes

Low risk

Participants blinded throughout the 2‐year follow‐up (unpublished information)

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Not able to determine

Selective reporting (reporting bias)

Unclear risk

Secondary outcomes were never reported

Other bias

Unclear risk

Not able to determine

Goynumer 2009

Methods

RCT

Participants

88 women

Inclusion criteria: regular menses, no risk of ovarian failure in personal or family history, ovarian reserve on transvaginal ultrasound (TVU) in normal range

Exclusion criteria: perimenopausal symptoms, abnormal BMI, ovarian cysts > 25 mm on TVU, pelvic surgery in previous year

Interventions

Laparoscopic interval sterilisation via electrocoagulation or mechanical clips

Outcomes

Post‐operative 10th month mean values of ovarian reserve i.e. serum FSH, LH, estradiol, inhibin‐B, antimullerian hormone. Total ovarian volume and anthral follicle count on TVU

Notes

General anaesthesia used

No review outcomes reported, therefore this study contributed no data to the review

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Random number table

Allocation concealment (selection bias)

Unclear risk

Not described

Blinding (performance bias and detection bias)
All outcomes

Unclear risk

Not described

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

No information on loss to follow‐up or postrandomisation exclusions

Selective reporting (reporting bias)

Unclear risk

Not able to determine

Other bias

Unclear risk

Not able to determine

Koetsawang 1978

Methods

Did not specify method of randomisation

Participants

300 women requesting sterilisation for family planning purposes at the Siriraj Hospital in Bangkok

Interventions

Unipolar electrocoagulation versus tubal ring via laparoscopy. All performed under local anaesthesia and intravenous sedation

Outcomes

Operative morbidity, technical failures and difficulties, failure rates, operative time, complaints

Notes

Postoperative evaluation blinding, prophylactic antibiotics for 5 days
Up to 54% loss to follow‐up at 12 months

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Not specified

Allocation concealment (selection bias)

Unclear risk

Assessed as a 'B' study (unclear allocation concealment) in original review

Blinding (performance bias and detection bias)
All outcomes

Low risk

Outcome assessor was blinded

Other bias

Low risk

The 2 groups had similar socio‐economic characteristics

Kohaut 2004

Methods

RCT pilot study of postpartum sterilisation techniques. Computer‐generated randomisation; sealed opaque envelope opened immediately before sterilisation

Participants

32 pregnant patients requesting sterilisation after vaginal delivery (25) or Caesarean section (4). Inclusion criteria: ≥ 21 years

Interventions

14 Filshie clip vs 15 Pomeroy method

Outcomes

Time from skin incision to closure, technical difficulties, surgeon's satisfaction, surgeon's preference (7/10 preferred Filshie to Pomeroy)

Notes

Baseline characteristics similar in the 2 groups. 2/32 study questionnaires lost = missing data (1 in each group). 1 post‐randomisation exclusion from the Filshie group as the woman had had a previous failed Filshie sterilisation and so Pomeroy was performed when surgeon saw old clips ‐ no other details provided

General or spinal anaesthesia used

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Computer‐generated randomisation

Allocation concealment (selection bias)

Low risk

Sealed opaque envelope opened immediately before sterilisation

Blinding (performance bias and detection bias)
All outcomes

Unclear risk

Not described

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Selective reporting (reporting bias)

Unclear risk

Other bias

Unclear risk

Baseline characteristics similar in the 2 groups

Pymar 2004

Methods

RCT. Women received a Filshie clip on 1 fallopian tube and a ring on the opposite side; site allocation was randomized.  Randomisation (via random number table) was performed following laparoscopic abdominal examination after excluding adhesions, endometriosis and pelvic masses. Allocation concealment by sequentially numbered sealed opaque envelopes. Group assignment determined the device that would be applied first and the side to which the first occlusion method would be placed. The subject was blind to her group, as were the monitoring and research staff

Participants

40 women in Pittsburg, USA, requesting sterilisation

Inclusion criteria: > 21years, literate and with telephone access

Exclusion criteria: allergy to local anaesthetic, morbid obesity > 100 kg, > 2 previous laparotomies, history of moderate to severe endometriosis, pelvic mass, current chronic pelvic pain, use of pain medications for any indication regularly during the past 2 weeks, history of depression or anxiety or other psychiatric disorder, allergy/intolerance to analgesics, plan for open laparoscopic procedure, previous tubal surgery, in‐operative discovery of dense adhesions, endometriosis or pelvic mass that required concurrent surgery

Interventions

Sterilisation with Filshie clip and fallopian ring on opposite fallopian tubes following topical bupivicaine application to the tubes (abdominal entry via laparoscopy)

Outcomes

Postoperative pain in first 24 h by visual analogue scale at 1 h, 2 h and 24 h

Notes

Rationale behind design was that women are apparently able to discriminate pain on each side of their abdomen after tubal occlusion (Kaplan 1990). ITT analysis; no significant difference in results when reported major (8) and minor (9); deviations from protocol were excluded

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Random number table

Allocation concealment (selection bias)

Low risk

Allocation concealment was by sequentially numbered sealed opaque envelopes

Blinding (performance bias and detection bias)
All outcomes

Low risk

Participants were blinded to group allocation, as were the monitoring and research staff

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Minimal loss to follow‐up. 8 women had major deviations from protocol and 17 women had minor deviations from protocol. Results were reported according to ITT

Selective reporting (reporting bias)

Unclear risk

Unable to determine

Other bias

Unclear risk

None noted

Qui 2011

Methods

Multicentre RCT conducted in 20 clinics in China between June 2007 and August 2008

Participants

2198 women requiring sterilisation

Inclusion criteria: 20‐40 years old, at least 2 children, married

Exclusion criteria: history of major abdominal surgery, epilepsy, neurosis, chronic pelvic inflammatory disease, acute infectious disease, body temperature > 37.5 °C, noted to have severe adhesions in previous operations

Interventions

1116 women sterilised via Uchida technique

1082 via silver clips

Outcomes

Pregnancy rates, morbidity, operative time, satisfaction

Follow‐up at 1 week, 3, 6, 12 months following sterilisation

Notes

Mostly interval sterilisation but < 2% were performed postabortion. Approximately 63% were performed in lactating women in whom menses had not resumed

Operations were performed under local anaesthetic and women were monitored for 2‐4 h after the operation

Surgical duration was significantly longer and amount of bleeding (classified as small, moderate or large amount) was greater in the Uchida arm

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

"participants were randomly assigned"

Allocation concealment (selection bias)

Unclear risk

"this information was placed in an envelope and delivered to the surgeon"

Blinding (performance bias and detection bias)
All outcomes

Unclear risk

Blinding of assessors was not described

Possibly high risk of performance bias for personnel

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

61 lost to follow‐up altogether with 20 lost in Uchida group and 41 lost in the clip group

Selective reporting (reporting bias)

Unclear risk

Did not report morbidity or postoperative/persistent pain. However, reported 'chief complaints' which were not significantly different between the study arms. Also, investigators only included data from women who attended all 3 follow‐up visits

Other bias

Unclear risk

Unable to determine. Baseline characteristics were similar

Rodriguez 2013

Methods

Multicentre RCT conducted by Family Health International in Thailand, Taiwan, Panama and the Phillipines with recruitment from April 1984 to June 1989

Participants

1400 postpartum women

Inclusion criteria: able to consent, within 42 days postpartum, ≥ 21 years old, normal physical and pelvic examination

Exclusion criteria: incapable of consenting, severe pre‐exisiting systemic disease, profound anaemia, anticipated concurrent surgery, limited accessibility for follow‐up, caesarean section

Interventions

Sterilisation within 72 h of delivery by:

Titanium clip (Filshie; 698 women) or

partial salpingectomy (Pomeroy; 702 women)

All procedures were by infra‐umbilical mini‐laparotomy incision of 1 cm‐2 cm in length

Outcomes

Failure rate. Follow‐up at 1, 6, 12, and 24 months following sterilisation

Notes

Loss to follow‐up was 51% at end of study. Method of anaesthesia was "local, epidural or spinal at the surgeon's discretion" Cumulative failure rates at one year were reported as 11 per 1000 for Filshie versus 2 per 1000 for partial salpingectomy; at two years, cumulative failure rates in this study were reported as 17 per 1000 versus 4 per 1000, respectively

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"computer‐generated code"

Allocation concealment (selection bias)

Low risk

"assignment was performed immediately before surgery after consent using an off‐site computer‐generated code that was unavailable to study staff"

Blinding (performance bias and detection bias)
All outcomes

Low risk

"the investigator in charge of follow‐up was" blinded to the procedure

Incomplete outcome data (attrition bias)
All outcomes

High risk

High attrition at 6 months with approximately 30% lost to follow‐up; at 1 year approximately 42% were lost to follow‐up, and at 2 years 51% were lost to follow‐up. 348 women were present in each group at the end of the study. 13 technical failures and random allocation errors occurred (but these did not result in pregnancy) ‐ it is not clear in which study groups these occurred

Selective reporting (reporting bias)

High risk

Only the primary outcome was reported

Other bias

Unclear risk

Unable to determine but "demographic variables were comparable between groups at baseline"

Siegle 2005

Methods

RCT conducted in the USA with recruitment between July 1999 and June 2001

Participants

109 women requesting sterilisation. Inclusion/exclusion criteria not stated

Interventions

Salpingectomy after bipolar coagulation (55 women) versus Pomeroy partial salpingectomy (54 women)

Outcomes

Pain at 6 h and 14 days postoperatively

Notes

Sterilisation via micro‐laparoscopy. Timing not clear, but probably interval sterilisation

Third‐year residents performed the procedure

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"computer‐generated randomisation code"

Allocation concealment (selection bias)

Low risk

"Technique assignment was written on a card placed in the sealed opaque envelope"; the "next consecutively numbered envelope" was allocated

Blinding (performance bias and detection bias)
All outcomes

Unclear risk

Not described

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Numbers analyzed/loss to follow‐up not described

Selective reporting (reporting bias)

Unclear risk

Not able to determine

Other bias

Unclear risk

Coagulation group was heavier than ligation group (180 vs 160 pounds) and had had more previous abdominal operations (12 vs 8)

Sitompul 1984

Methods

Not specified method of randomisation

Participants

300 women requesting sterilisation at the University Hospital in Medan, Indonesia
Exclusion criteria: heart, pulmonary, endocrine or other systemic illness, PID or vulvovaginal infections

Interventions

Modified Pomeroy technique (via minilaparotomy or culdoscopy) versus electrocoagulation (via laparoscopy). All under local anaesthesia and 10 mg intravenous valium

Outcomes

Operative time, hospitalisation, postoperative complications, failure rates

Notes

Interval sterilisation

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Not described

Allocation concealment (selection bias)

Unclear risk

Not described

Blinding (performance bias and detection bias)
All outcomes

Unclear risk

Not described

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

5 women were excluded after randomisation (3 Pomeroy, 2 electrocoagulation)

Selective reporting (reporting bias)

Unclear risk

Unable to determine

Other bias

Unclear risk

Unable to determine

Sokal 2000

Methods

Multicentre RCT conducted by FHI from 1984 to 1990 in centres in Panama, Peru, Kenya, Brazil, Mexico, Indonesia, Thailand and the Dominican Republic

Participants

2746 women requiring interval sterilisation

Inclusion criteria: at least 21 years old, legally able to consent, normal physical and pelvic examination

Exclusion criteria: pregnant within last 42 days, pre‐existing chronic disease, no conconmitant surgical procedures needed except curettage

Interventions

Titanium clip (Filshie;1381 women) or

tubal ring (1365 women)

Randomisation was in 2 groups: 1) access via minilaparotomy (5 centres) 482 Filshie, 453 ring; 2) access via laparoscopy (7 centres) 919 Filshie, 912 ring

Outcomes

Pregnancy, adverse events, hospital admissions, further surgery

Follow‐up conducted at 1, 6, and 12 months following sterilisation. A 24‐month follow‐up "was planned for a subset" of women

Notes

Report combined data from 2 studies, one utilising a minilapraotomy approach, the other utilising laparoscopy. 'Experienced surgeons' performed the procedures

There were more tubal injuries in the ring group (e.g. tubal transections, haematomas) and also more surgical difficulties and failures Filshie clip expulsions occurred at 10, 30 and 34 months after sterilisation in 3 women

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"computer‐generated randomisation scheme"

Allocation concealment (selection bias)

Low risk

"sealed, sequentially numbered opaque envelope" provided by FHI

Blinding (performance bias and detection bias)
All outcomes

Low risk

Outcome assessors were blinded

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Loss to follow‐up was relatively low, approximately 7% (low) for the early follow‐up visit and 18% at 12 months. 30 and 41 protocol violations of inclusion/exclusion criteria in Filshi and tubal ring groups respectively. Characteristics of women lost to follow‐up were similar in both groups

Selective reporting (reporting bias)

Unclear risk

Reported treated population data mainly (i.e. not ITT data)

Other bias

Unclear risk

One centre used its own randomisation schedule and randomized 68 women (34 to each group), therefore assignment was not according to FHI randomisation schedule

Stovall 1991

Methods

Randomisation by computer‐generated schedule

Participants

365 women at the University of Tennessee, Memphis

Interventions

Spring‐loaded clip (Hulka‐Clemens) versus tubal ring (Falope ring). All procedures via laparoscopy

Outcomes

Failure rates

Notes

All procedures performed by third‐year residents. Urine hCG within 72 h before procedure. Methylene‐blue test with no spillage recorded

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Computer‐generated schedule

Allocation concealment (selection bias)

Unclear risk

Not described

Blinding (performance bias and detection bias)
All outcomes

Unclear risk

Not described

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

No post‐randomisation exclusion or losses to follow‐up were reported

Selective reporting (reporting bias)

Unclear risk

Unable to determine

Other bias

Unclear risk

Both groups had similar socio‐demographic characteristics

Toplis 1988

Methods

Randomisation not specified. Concealment of allocation by envelope opened immediately before operation

Participants

200 non pregnant women at the Churchill Hospital, Oxford

Interventions

Spring‐loaded clip (Hulka‐Clemens) versus Filshie clip (titanium clip) via laparoscopy

Outcomes

Operative morbidity, operative time, complaints

Notes

Interval sterilisation

Authors as the only surgeons

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Not described

Allocation concealment (selection bias)

Low risk

Concealment of allocation by envelope opened immediately before operation

Blinding (performance bias and detection bias)
All outcomes

Unclear risk

Not described

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Two women from the Hulka clip group were excluded from the study because of technical failure

Selective reporting (reporting bias)

Unclear risk

Unable to determine

Other bias

Unclear risk

Unable to determine. Women in the Filshie group were slightly heavier than those in the Hulka clip group

WHO 1982

Methods

Multicenter, multinational randomized study. Randomisation centrally generated by WHO. Concealment of allocation by sealed, sequentially numbered opaque envelopes

Participants

1827 healthy women with at least one child and eligible for both interventions. Exclusion criteria: pelvic pathologies, history of previous PID or peritonitis, scar below the umbilicus or any condition which would increase the risk of any surgical procedure
Conducted in Bangkok, Havana, London, Los Angeles, Santiago, Seoul, Singapore, Sydney

Interventions

Modified Pomeroy method via minilaparotomy versus electrocoagulation via laparoscopy

Outcomes

Major and minor morbidity, technical failures, postoperative complaints

Notes

Interval sterilisation

Anaesthesia standardised within individual centres according to routine practice in the institution. In the 3 high‐income country centres (London, Los Angeles, Sydney) all operations were performed under general anaesthesia, whereas in 2 middle‐ or low‐income country centres (Bangkok, Seoul) local anaesthesia was used for both procedures. In Havana and Singapore all women in the electrocoagulation group received general anaesthesia and most Pomeroy procedures were done under spinal/epidural anaesthesia. In Santiago all Pomeroy procedures were performed under spinal anaesthesia, and all electrocoagulation procedures under local anaesthesia. All centres used sedatives for pre‐medication were used
All procedures performed by experienced surgeons

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Randomisation generated centrally by WHO

Allocation concealment (selection bias)

Low risk

Concealment of allocation by sealed, sequentially numbered opaque envelopes. Assessed as an 'A' study) in original review

Blinding (performance bias and detection bias)
All outcomes

Unclear risk

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

The post‐randomisation exclusion rate was about 12% (121 women) in the Pomeroy group and about 10% (96 women) in the electrocoagulation group due to protocol violations

Selective reporting (reporting bias)

Unclear risk

Unable to determine

Other bias

High risk

There were important differences in baseline characteristics mainly due to 1 centre (Bangkok) where women in the electrocoagulation group were older, had more living children and had been married longer. Also, women in the Pomeroy group were lighter and had a lower ponderal index, mainly due to the contribution of 2 centres (Bangkok and Havana).These differences were statistically significant for the Bangkok centre

Yan 1990

Methods

Randomisation not specified. Concealment of allocation by sealed preprinted labels

Participants

200 women postpartum at the Tri‐Service General Hospital, Taipei, Taiwan

Interventions

Pomeroy method versus Filshie clip, all via subumbilical minilaparotomy. 88% under epidural anaesthesia and the remainder under local anaesthesia

Outcomes

Complications, menstrual irregularities, failure rates

Notes

Postpartum sterilisation with 24 month follow‐up. Pregnancy rates at 24 months were 1/70 and 0/78 in the PS and clip arms, respectively.

Blinding of postoperative evaluation. All procedures were performed by one of the authors

This trial is a subset of the Rodriguez 2013 report but includes more outcomes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Not described

Allocation concealment (selection bias)

Low risk

Concealment of allocation by sealed preprinted labels

Blinding (performance bias and detection bias)
All outcomes

Low risk

Outcome assessor blinded.

Selective reporting (reporting bias)

Unclear risk

Unable to determine

Other bias

Low risk

Selected socio‐demographic characteristics (age, total live births and previous contraceptive use) were found to be similar between groups

Abbreviations

BMI: body mass index
FSH: follicle‐stimulating hormone
h: hour(s)
hCG: human chorionic gonadotropin
ITT: intention‐to‐treat analysis
LH: lutenising hormone
PID: pelvic inflammatory disease
RCT: randomized controlled trial

TVU: transvaginal ultrasound
UTI: urinary tract infection
WHO: World Health Organization

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Alvarez 1989

RCT (uncertain whether quasi‐randomised) of post‐tubal sterilisation hormone levels following Pomeroy or Uchida techniques 17/38 completed the protocol and only 17 were included in analyses

Bordahl 1984

Quasi‐RCT with about 40% postrandomisation exclusions

Chapa 2015

RCT of methods of access (vaginoscopy vs hysteroscopy) for hysteroscopic sterilisation (Essure), not of techniques for interrupting tubal patency

Dueholm 1986

Not an RCT

Lee 1991

Women were 'randomized' (no details provided) before surgery to Hulka clips or modified Pomeroy technique, but at the time of surgery, those found to have tubal disease underwent sterilisation with standard modified Pomeroy technique and were then analyzed in that group

Lipscomb 1994

An RCT of chromotubation vs no chromotubation to confirm poststerilisation tubal occlusion. Although women were apparently also randomized to the sterilisation method (tubal ring, electrocautery, or Hulka clips), comparisons of these methods were not the objective of the study and outcomes and losses to follow‐up were not described separately for each method

Madrigal 1977

ITT analysis was not performed. 1 participant from the clip group was changed to the electrocoagulation group due to a technical problem and was included in the latter for the further analysis

Murray 1992

Quasi‐RCT

Rivera 1989

Quasi‐RCT. The groups were divided into equal numbers of women. In addition, a fourth group was taken as a control group

Sahwi 1989

Quasi‐RCT. The groups were divided into equal numbers of women

Abbreviations

ITT: intention‐to‐treat analysis
RCT: randomized controlled trial

Data and analyses

Open in table viewer
Comparison 1. Tubal ring versus clip

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Major morbidity: total Show forest plot

1

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

Analysis 1.1

Comparison 1 Tubal ring versus clip, Outcome 1 Major morbidity: total.

Comparison 1 Tubal ring versus clip, Outcome 1 Major morbidity: total.

1.1 Procedure‐related injuries requiring additional operation or blood transfusion

1

545

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.14 [0.00, 7.05]

2 Minor morbidity: total Show forest plot

2

842

Peto Odds Ratio (Peto, Fixed, 95% CI)

2.15 [1.22, 3.78]

Analysis 1.2

Comparison 1 Tubal ring versus clip, Outcome 2 Minor morbidity: total.

Comparison 1 Tubal ring versus clip, Outcome 2 Minor morbidity: total.

3 Minor morbidity: details Show forest plot

3

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

Analysis 1.3

Comparison 1 Tubal ring versus clip, Outcome 3 Minor morbidity: details.

Comparison 1 Tubal ring versus clip, Outcome 3 Minor morbidity: details.

3.1 Procedure related injuries with no additional operation

3

3575

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.95 [1.36, 2.78]

3.2 Urogenital infections

3

3145

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.88 [0.83, 4.28]

3.3 Wound infection

3

3144

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.17 [0.73, 1.87]

3.4 Postoperative temperature > 38 °C without hospitalisation

1

296

Peto Odds Ratio (Peto, Fixed, 95% CI)

7.49 [0.15, 377.52]

4 Technical failures Show forest plot

3

3476

Peto Odds Ratio (Peto, Fixed, 95% CI)

3.93 [2.43, 6.35]

Analysis 1.4

Comparison 1 Tubal ring versus clip, Outcome 4 Technical failures.

Comparison 1 Tubal ring versus clip, Outcome 4 Technical failures.

5 Technical difficulties Show forest plot

3

3590

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.13 [0.87, 1.46]

Analysis 1.5

Comparison 1 Tubal ring versus clip, Outcome 5 Technical difficulties.

Comparison 1 Tubal ring versus clip, Outcome 5 Technical difficulties.

6 Failure rate: total Show forest plot

4

3822

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.72 [0.33, 1.57]

Analysis 1.6

Comparison 1 Tubal ring versus clip, Outcome 6 Failure rate: total.

Comparison 1 Tubal ring versus clip, Outcome 6 Failure rate: total.

7 Failure rate: details Show forest plot

2

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

Analysis 1.7

Comparison 1 Tubal ring versus clip, Outcome 7 Failure rate: details.

Comparison 1 Tubal ring versus clip, Outcome 7 Failure rate: details.

7.1 Failure rate ≤ 1 year, total

2

2629

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.85 [0.23, 3.14]

7.2 Failure rate ≤ 1 year, extrauterine pregnancy

1

2202

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.0 [0.0, 0.0]

7.3 Failure rate > 1 year, extrauterine pregnancy

1

427

Peto Odds Ratio (Peto, Fixed, 95% CI)

8.11 [0.16, 410.33]

8 Operative time Show forest plot

1

297

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

Analysis 1.8

Comparison 1 Tubal ring versus clip, Outcome 8 Operative time.

Comparison 1 Tubal ring versus clip, Outcome 8 Operative time.

9 Hospital stay > 24 h Show forest plot

1

Odds Ratio (M‐H, Fixed, 95% CI)

Totals not selected

Analysis 1.9

Comparison 1 Tubal ring versus clip, Outcome 9 Hospital stay > 24 h.

Comparison 1 Tubal ring versus clip, Outcome 9 Hospital stay > 24 h.

10 Complaints Show forest plot

4

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

Analysis 1.10

Comparison 1 Tubal ring versus clip, Outcome 10 Complaints.

Comparison 1 Tubal ring versus clip, Outcome 10 Complaints.

10.1 Postoperative pain < 24 h

3

922

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.14 [0.88, 1.48]

10.2 Postoperative analgesic use

1

70

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.70 [0.28, 1.79]

10.3 Cramping pain during first week after surgery

1

70

Peto Odds Ratio (Peto, Fixed, 95% CI)

5.24 [1.52, 18.00]

11 Menstrual irregularities Show forest plot

2

612

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.61 [0.75, 3.49]

Analysis 1.11

Comparison 1 Tubal ring versus clip, Outcome 11 Menstrual irregularities.

Comparison 1 Tubal ring versus clip, Outcome 11 Menstrual irregularities.

Open in table viewer
Comparison 2. Partial salpingectomy (modified Pomeroy) versus electrocoagulation

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Operative mortality Show forest plot

1

1610

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.0 [0.0, 0.0]

Analysis 2.1

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 1 Operative mortality.

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 1 Operative mortality.

2 Major morbidity: total Show forest plot

2

1905

Peto Odds Ratio (Peto, Fixed, 95% CI)

2.87 [1.13, 7.25]

Analysis 2.2

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 2 Major morbidity: total.

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 2 Major morbidity: total.

3 Major morbidity: details Show forest plot

2

Odds Ratio (M‐H, Random, 95% CI)

Subtotals only

Analysis 2.3

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 3 Major morbidity: details.

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 3 Major morbidity: details.

3.1 Procedure‐related injuries requiring additional operation or blood transfusion

2

1905

Odds Ratio (M‐H, Random, 95% CI)

1.90 [0.19, 18.96]

3.2 Rehospitalisation as a consequence of operation

1

295

Odds Ratio (M‐H, Random, 95% CI)

5.74 [0.73, 45.09]

4 Minor morbidity: total Show forest plot

2

1905

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.60 [1.10, 2.33]

Analysis 2.4

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 4 Minor morbidity: total.

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 4 Minor morbidity: total.

5 Minor morbidity: details Show forest plot

2

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

Analysis 2.5

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 5 Minor morbidity: details.

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 5 Minor morbidity: details.

5.1 Procedure‐related injuries with no additional operation

1

1610

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.53 [0.06, 5.11]

5.2 Urogenital infections

1

1610

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.81 [0.43, 1.50]

5.3 Wound infection

1

1610

Peto Odds Ratio (Peto, Fixed, 95% CI)

2.49 [1.54, 4.04]

5.4 Postoperative temperature > 38 °C without hospitalisation

1

295

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.45 [0.18, 11.77]

6 Failure rate: total Show forest plot

1

295

Peto Odds Ratio (Peto, Fixed, 95% CI)

4.47 [0.07, 286.78]

Analysis 2.6

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 6 Failure rate: total.

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 6 Failure rate: total.

6.1 Failure rate, total

1

295

Peto Odds Ratio (Peto, Fixed, 95% CI)

4.47 [0.07, 286.78]

7 Failure rate: details Show forest plot

1

295

Peto Odds Ratio (Peto, Fixed, 95% CI)

4.47 [0.07, 286.78]

Analysis 2.7

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 7 Failure rate: details.

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 7 Failure rate: details.

7.1 Failure rate > 1 year, total

1

295

Peto Odds Ratio (Peto, Fixed, 95% CI)

4.47 [0.07, 286.78]

8 Hospital stay more 24 h Show forest plot

1

108

Odds Ratio (M‐H, Fixed, 95% CI)

0.48 [0.08, 2.74]

Analysis 2.8

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 8 Hospital stay more 24 h.

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 8 Hospital stay more 24 h.

9 Complaints Show forest plot

3

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

Analysis 2.9

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 9 Complaints.

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 9 Complaints.

9.1 Postoperative pain < 24 h

2

1905

Peto Odds Ratio (Peto, Fixed, 95% CI)

3.85 [2.91, 5.10]

9.2 Postoperative analgesic use

1

109

Peto Odds Ratio (Peto, Fixed, 95% CI)

2.05 [0.40, 10.56]

9.3 Persistent pain at follow‐up visit

1

1610

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.09 [0.81, 1.47]

Open in table viewer
Comparison 3. Tubal ring versus electrocoagulation

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Major morbidity: total Show forest plot

2

596

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.14 [0.00, 7.01]

Analysis 3.1

Comparison 3 Tubal ring versus electrocoagulation, Outcome 1 Major morbidity: total.

Comparison 3 Tubal ring versus electrocoagulation, Outcome 1 Major morbidity: total.

2 Major morbidity: details Show forest plot

1

298

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.14 [0.00, 7.01]

Analysis 3.2

Comparison 3 Tubal ring versus electrocoagulation, Outcome 2 Major morbidity: details.

Comparison 3 Tubal ring versus electrocoagulation, Outcome 2 Major morbidity: details.

2.1 Procedure‐related injuries requiring additional operation or blood transfusion

1

298

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.14 [0.00, 7.01]

3 Minor morbidity: total Show forest plot

2

596

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.97 [0.50, 1.87]

Analysis 3.3

Comparison 3 Tubal ring versus electrocoagulation, Outcome 3 Minor morbidity: total.

Comparison 3 Tubal ring versus electrocoagulation, Outcome 3 Minor morbidity: total.

4 Minor morbidity: details Show forest plot

2

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

Analysis 3.4

Comparison 3 Tubal ring versus electrocoagulation, Outcome 4 Minor morbidity: details.

Comparison 3 Tubal ring versus electrocoagulation, Outcome 4 Minor morbidity: details.

4.1 Procedure‐related injuries with no additional operation

2

596

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.76 [0.17, 3.38]

4.2 Urogenital infections

1

296

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.03 [0.14, 7.37]

4.3 Wound infection

1

296

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.93 [0.38, 2.25]

4.4 Postoperative temperature > 38 °C without hospitalisation

2

594

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.37 [0.31, 6.06]

5 Technical failures: total Show forest plot

2

596

Peto Odds Ratio (Peto, Fixed, 95% CI)

3.42 [0.59, 19.81]

Analysis 3.5

Comparison 3 Tubal ring versus electrocoagulation, Outcome 5 Technical failures: total.

Comparison 3 Tubal ring versus electrocoagulation, Outcome 5 Technical failures: total.

6 Technical difficulties Show forest plot

1

298

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.14 [0.01, 1.33]

Analysis 3.6

Comparison 3 Tubal ring versus electrocoagulation, Outcome 6 Technical difficulties.

Comparison 3 Tubal ring versus electrocoagulation, Outcome 6 Technical difficulties.

7 Failure rate: total Show forest plot

1

160

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.0 [0.0, 0.0]

Analysis 3.7

Comparison 3 Tubal ring versus electrocoagulation, Outcome 7 Failure rate: total.

Comparison 3 Tubal ring versus electrocoagulation, Outcome 7 Failure rate: total.

7.1 Failure rate, total

1

160

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.0 [0.0, 0.0]

8 Operative time Show forest plot

1

298

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

Analysis 3.8

Comparison 3 Tubal ring versus electrocoagulation, Outcome 8 Operative time.

Comparison 3 Tubal ring versus electrocoagulation, Outcome 8 Operative time.

9 Complaints Show forest plot

2

Odds Ratio (M‐H, Random, 95% CI)

Subtotals only

Analysis 3.9

Comparison 3 Tubal ring versus electrocoagulation, Outcome 9 Complaints.

Comparison 3 Tubal ring versus electrocoagulation, Outcome 9 Complaints.

9.1 Postoperative pain < 24 h

2

596

Odds Ratio (M‐H, Random, 95% CI)

3.40 [1.17, 9.84]

9.2 Postoperative analgesic use

1

298

Odds Ratio (M‐H, Random, 95% CI)

2.51 [1.00, 6.30]

9.3 Persistent pain at follow‐up visit

2

594

Odds Ratio (M‐H, Random, 95% CI)

1.22 [0.75, 1.97]

10 Menstrual irregularities Show forest plot

1

296

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.90 [0.56, 1.45]

Analysis 3.10

Comparison 3 Tubal ring versus electrocoagulation, Outcome 10 Menstrual irregularities.

Comparison 3 Tubal ring versus electrocoagulation, Outcome 10 Menstrual irregularities.

Open in table viewer
Comparison 4. Partial salpingectomy (PS) versus clip

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Operative mortality Show forest plot

1

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

Analysis 4.1

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 1 Operative mortality.

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 1 Operative mortality.

1.1 Uchida vs silver clip

1

2198

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.0 [0.0, 0.0]

2 Major morbidity: total Show forest plot

1

2198

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.0 [0.0, 0.0]

Analysis 4.2

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 2 Major morbidity: total.

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 2 Major morbidity: total.

2.1 Uchida vs silver clip

1

2198

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.0 [0.0, 0.0]

3 Minor morbidity: total Show forest plot

1

193

Peto Odds Ratio (Peto, Fixed, 95% CI)

7.39 [0.46, 119.01]

Analysis 4.3

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 3 Minor morbidity: total.

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 3 Minor morbidity: total.

4 Minor morbidity: details Show forest plot

1

193

Peto Odds Ratio (Peto, Fixed, 95% CI)

7.39 [0.46, 119.01]

Analysis 4.4

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 4 Minor morbidity: details.

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 4 Minor morbidity: details.

4.1 Procedure related injuries with no additional operation

1

193

Peto Odds Ratio (Peto, Fixed, 95% CI)

7.39 [0.46, 119.01]

5 Technical failures Show forest plot

1

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

Analysis 4.5

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 5 Technical failures.

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 5 Technical failures.

5.1 Uchida vs silver clip

1

2198

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.18 [0.08, 0.40]

6 Technical difficulties Show forest plot

1

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

Analysis 4.6

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 6 Technical difficulties.

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 6 Technical difficulties.

6.1 Uchida vs silver clip

1

2198

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.97 [0.42, 2.24]

7 Failure rate (12 months) : total Show forest plot

2

3537

Odds Ratio (M‐H, Random, 95% CI)

0.21 [0.05, 0.84]

Analysis 4.7

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 7 Failure rate (12 months) : total.

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 7 Failure rate (12 months) : total.

7.1 Pomeroy vs Filshie

1

1400

Odds Ratio (M‐H, Random, 95% CI)

0.22 [0.05, 1.02]

7.2 Uchida vs silver clip

1

2137

Odds Ratio (M‐H, Random, 95% CI)

0.19 [0.01, 3.95]

8 Operative time Show forest plot

2

2223

Mean Difference (IV, Fixed, 95% CI)

4.26 [3.65, 4.86]

Analysis 4.8

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 8 Operative time.

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 8 Operative time.

8.1 Pomeroy vs Filshie

1

25

Mean Difference (IV, Fixed, 95% CI)

6.70 [0.77, 12.63]

8.2 Uchida vs silver clip

1

2198

Mean Difference (IV, Fixed, 95% CI)

4.23 [3.62, 4.84]

9 All complaints Show forest plot

1

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

Analysis 4.9

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 9 All complaints.

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 9 All complaints.

9.1 Uchida vs silver clip

1

2137

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.30 [0.92, 1.82]

10 Menstrual irregularities Show forest plot

2

2283

Odds Ratio (M‐H, Random, 95% CI)

1.43 [0.73, 2.79]

Analysis 4.10

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 10 Menstrual irregularities.

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 10 Menstrual irregularities.

10.1 Pomeroy vs Filshie

1

146

Odds Ratio (M‐H, Random, 95% CI)

2.49 [0.88, 7.05]

10.2 Uchida vs silver clip

1

2137

Odds Ratio (M‐H, Random, 95% CI)

1.16 [0.90, 1.49]

11 Women's satisfaction Show forest plot

1

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

Analysis 4.11

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 11 Women's satisfaction.

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 11 Women's satisfaction.

11.1 Uchida vs silver clip

1

2110

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.27 [0.99, 1.64]

12 Surgeon's satisfaction Show forest plot

Other data

No numeric data

Analysis 4.12

Study

.

.

Kohaut 2004

Seven out of 10 surgeons performing a total of 29 sterilisations preferred the Filshie clip method to the Pomeroy method.



Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 12 Surgeon's satisfaction.

Open in table viewer
Comparison 5. Hulka versus Filshie clip

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Minor morbidity: total Show forest plot

1

197

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.14 [0.00, 7.32]

Analysis 5.1

Comparison 5 Hulka versus Filshie clip, Outcome 1 Minor morbidity: total.

Comparison 5 Hulka versus Filshie clip, Outcome 1 Minor morbidity: total.

2 Minor morbidity: details Show forest plot

2

Odds Ratio (M‐H, Random, 95% CI)

Subtotals only

Analysis 5.2

Comparison 5 Hulka versus Filshie clip, Outcome 2 Minor morbidity: details.

Comparison 5 Hulka versus Filshie clip, Outcome 2 Minor morbidity: details.

2.1 Procedure‐related injuries with no additional operation

2

2322

Odds Ratio (M‐H, Random, 95% CI)

1.57 [0.73, 3.36]

2.2 Urogenital infection

1

1910

Odds Ratio (M‐H, Random, 95% CI)

2.40 [0.62, 9.30]

2.3 Wound complications

1

1910

Odds Ratio (M‐H, Random, 95% CI)

0.86 [0.63, 1.17]

3 Technical failures Show forest plot

2

2325

Odds Ratio (M‐H, Random, 95% CI)

1.04 [0.10, 11.33]

Analysis 5.3

Comparison 5 Hulka versus Filshie clip, Outcome 3 Technical failures.

Comparison 5 Hulka versus Filshie clip, Outcome 3 Technical failures.

4 Technical difficulties Show forest plot

2

2323

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.51 [1.09, 2.10]

Analysis 5.4

Comparison 5 Hulka versus Filshie clip, Outcome 4 Technical difficulties.

Comparison 5 Hulka versus Filshie clip, Outcome 4 Technical difficulties.

5 Failure rate: total Show forest plot

1

1441

Odds Ratio (M‐H, Fixed, 95% CI)

6.20 [0.75, 51.66]

Analysis 5.5

Comparison 5 Hulka versus Filshie clip, Outcome 5 Failure rate: total.

Comparison 5 Hulka versus Filshie clip, Outcome 5 Failure rate: total.

6 Operative time Show forest plot

1

197

Mean Difference (IV, Fixed, 95% CI)

0.70 [‐0.04, 1.44]

Analysis 5.6

Comparison 5 Hulka versus Filshie clip, Outcome 6 Operative time.

Comparison 5 Hulka versus Filshie clip, Outcome 6 Operative time.

7 Complaints Show forest plot

1

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

Analysis 5.7

Comparison 5 Hulka versus Filshie clip, Outcome 7 Complaints.

Comparison 5 Hulka versus Filshie clip, Outcome 7 Complaints.

7.1 Postoperative pain < 24 h

1

197

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.74 [0.99, 3.03]

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
Figuras y tablas -
Figure 1

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Comparison 1 Tubal ring versus clip, Outcome 1 Major morbidity: total.
Figuras y tablas -
Analysis 1.1

Comparison 1 Tubal ring versus clip, Outcome 1 Major morbidity: total.

Comparison 1 Tubal ring versus clip, Outcome 2 Minor morbidity: total.
Figuras y tablas -
Analysis 1.2

Comparison 1 Tubal ring versus clip, Outcome 2 Minor morbidity: total.

Comparison 1 Tubal ring versus clip, Outcome 3 Minor morbidity: details.
Figuras y tablas -
Analysis 1.3

Comparison 1 Tubal ring versus clip, Outcome 3 Minor morbidity: details.

Comparison 1 Tubal ring versus clip, Outcome 4 Technical failures.
Figuras y tablas -
Analysis 1.4

Comparison 1 Tubal ring versus clip, Outcome 4 Technical failures.

Comparison 1 Tubal ring versus clip, Outcome 5 Technical difficulties.
Figuras y tablas -
Analysis 1.5

Comparison 1 Tubal ring versus clip, Outcome 5 Technical difficulties.

Comparison 1 Tubal ring versus clip, Outcome 6 Failure rate: total.
Figuras y tablas -
Analysis 1.6

Comparison 1 Tubal ring versus clip, Outcome 6 Failure rate: total.

Comparison 1 Tubal ring versus clip, Outcome 7 Failure rate: details.
Figuras y tablas -
Analysis 1.7

Comparison 1 Tubal ring versus clip, Outcome 7 Failure rate: details.

Comparison 1 Tubal ring versus clip, Outcome 8 Operative time.
Figuras y tablas -
Analysis 1.8

Comparison 1 Tubal ring versus clip, Outcome 8 Operative time.

Comparison 1 Tubal ring versus clip, Outcome 9 Hospital stay > 24 h.
Figuras y tablas -
Analysis 1.9

Comparison 1 Tubal ring versus clip, Outcome 9 Hospital stay > 24 h.

Comparison 1 Tubal ring versus clip, Outcome 10 Complaints.
Figuras y tablas -
Analysis 1.10

Comparison 1 Tubal ring versus clip, Outcome 10 Complaints.

Comparison 1 Tubal ring versus clip, Outcome 11 Menstrual irregularities.
Figuras y tablas -
Analysis 1.11

Comparison 1 Tubal ring versus clip, Outcome 11 Menstrual irregularities.

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 1 Operative mortality.
Figuras y tablas -
Analysis 2.1

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 1 Operative mortality.

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 2 Major morbidity: total.
Figuras y tablas -
Analysis 2.2

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 2 Major morbidity: total.

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 3 Major morbidity: details.
Figuras y tablas -
Analysis 2.3

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 3 Major morbidity: details.

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 4 Minor morbidity: total.
Figuras y tablas -
Analysis 2.4

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 4 Minor morbidity: total.

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 5 Minor morbidity: details.
Figuras y tablas -
Analysis 2.5

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 5 Minor morbidity: details.

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 6 Failure rate: total.
Figuras y tablas -
Analysis 2.6

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 6 Failure rate: total.

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 7 Failure rate: details.
Figuras y tablas -
Analysis 2.7

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 7 Failure rate: details.

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 8 Hospital stay more 24 h.
Figuras y tablas -
Analysis 2.8

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 8 Hospital stay more 24 h.

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 9 Complaints.
Figuras y tablas -
Analysis 2.9

Comparison 2 Partial salpingectomy (modified Pomeroy) versus electrocoagulation, Outcome 9 Complaints.

Comparison 3 Tubal ring versus electrocoagulation, Outcome 1 Major morbidity: total.
Figuras y tablas -
Analysis 3.1

Comparison 3 Tubal ring versus electrocoagulation, Outcome 1 Major morbidity: total.

Comparison 3 Tubal ring versus electrocoagulation, Outcome 2 Major morbidity: details.
Figuras y tablas -
Analysis 3.2

Comparison 3 Tubal ring versus electrocoagulation, Outcome 2 Major morbidity: details.

Comparison 3 Tubal ring versus electrocoagulation, Outcome 3 Minor morbidity: total.
Figuras y tablas -
Analysis 3.3

Comparison 3 Tubal ring versus electrocoagulation, Outcome 3 Minor morbidity: total.

Comparison 3 Tubal ring versus electrocoagulation, Outcome 4 Minor morbidity: details.
Figuras y tablas -
Analysis 3.4

Comparison 3 Tubal ring versus electrocoagulation, Outcome 4 Minor morbidity: details.

Comparison 3 Tubal ring versus electrocoagulation, Outcome 5 Technical failures: total.
Figuras y tablas -
Analysis 3.5

Comparison 3 Tubal ring versus electrocoagulation, Outcome 5 Technical failures: total.

Comparison 3 Tubal ring versus electrocoagulation, Outcome 6 Technical difficulties.
Figuras y tablas -
Analysis 3.6

Comparison 3 Tubal ring versus electrocoagulation, Outcome 6 Technical difficulties.

Comparison 3 Tubal ring versus electrocoagulation, Outcome 7 Failure rate: total.
Figuras y tablas -
Analysis 3.7

Comparison 3 Tubal ring versus electrocoagulation, Outcome 7 Failure rate: total.

Comparison 3 Tubal ring versus electrocoagulation, Outcome 8 Operative time.
Figuras y tablas -
Analysis 3.8

Comparison 3 Tubal ring versus electrocoagulation, Outcome 8 Operative time.

Comparison 3 Tubal ring versus electrocoagulation, Outcome 9 Complaints.
Figuras y tablas -
Analysis 3.9

Comparison 3 Tubal ring versus electrocoagulation, Outcome 9 Complaints.

Comparison 3 Tubal ring versus electrocoagulation, Outcome 10 Menstrual irregularities.
Figuras y tablas -
Analysis 3.10

Comparison 3 Tubal ring versus electrocoagulation, Outcome 10 Menstrual irregularities.

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 1 Operative mortality.
Figuras y tablas -
Analysis 4.1

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 1 Operative mortality.

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 2 Major morbidity: total.
Figuras y tablas -
Analysis 4.2

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 2 Major morbidity: total.

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 3 Minor morbidity: total.
Figuras y tablas -
Analysis 4.3

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 3 Minor morbidity: total.

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 4 Minor morbidity: details.
Figuras y tablas -
Analysis 4.4

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 4 Minor morbidity: details.

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 5 Technical failures.
Figuras y tablas -
Analysis 4.5

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 5 Technical failures.

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 6 Technical difficulties.
Figuras y tablas -
Analysis 4.6

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 6 Technical difficulties.

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 7 Failure rate (12 months) : total.
Figuras y tablas -
Analysis 4.7

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 7 Failure rate (12 months) : total.

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 8 Operative time.
Figuras y tablas -
Analysis 4.8

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 8 Operative time.

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 9 All complaints.
Figuras y tablas -
Analysis 4.9

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 9 All complaints.

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 10 Menstrual irregularities.
Figuras y tablas -
Analysis 4.10

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 10 Menstrual irregularities.

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 11 Women's satisfaction.
Figuras y tablas -
Analysis 4.11

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 11 Women's satisfaction.

Study

.

.

Kohaut 2004

Seven out of 10 surgeons performing a total of 29 sterilisations preferred the Filshie clip method to the Pomeroy method.

Figuras y tablas -
Analysis 4.12

Comparison 4 Partial salpingectomy (PS) versus clip, Outcome 12 Surgeon's satisfaction.

Comparison 5 Hulka versus Filshie clip, Outcome 1 Minor morbidity: total.
Figuras y tablas -
Analysis 5.1

Comparison 5 Hulka versus Filshie clip, Outcome 1 Minor morbidity: total.

Comparison 5 Hulka versus Filshie clip, Outcome 2 Minor morbidity: details.
Figuras y tablas -
Analysis 5.2

Comparison 5 Hulka versus Filshie clip, Outcome 2 Minor morbidity: details.

Comparison 5 Hulka versus Filshie clip, Outcome 3 Technical failures.
Figuras y tablas -
Analysis 5.3

Comparison 5 Hulka versus Filshie clip, Outcome 3 Technical failures.

Comparison 5 Hulka versus Filshie clip, Outcome 4 Technical difficulties.
Figuras y tablas -
Analysis 5.4

Comparison 5 Hulka versus Filshie clip, Outcome 4 Technical difficulties.

Comparison 5 Hulka versus Filshie clip, Outcome 5 Failure rate: total.
Figuras y tablas -
Analysis 5.5

Comparison 5 Hulka versus Filshie clip, Outcome 5 Failure rate: total.

Comparison 5 Hulka versus Filshie clip, Outcome 6 Operative time.
Figuras y tablas -
Analysis 5.6

Comparison 5 Hulka versus Filshie clip, Outcome 6 Operative time.

Comparison 5 Hulka versus Filshie clip, Outcome 7 Complaints.
Figuras y tablas -
Analysis 5.7

Comparison 5 Hulka versus Filshie clip, Outcome 7 Complaints.

Summary of findings for the main comparison. Summary of findings: ring versus clip

Tubal ring compared with tubal clip for interval sterilisation

Patient or population: women > 6 weeks postpartum requesting tubal sterilisation

Settings: any

Intervention: tubal ring

Comparison: tubal clip

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Clip

Ring

Major morbidity: total

Low risk population

OR 0.14

(0.00 to 7.05)

545

(1)

⊕⊕⊝⊝
low1,2

Only one event occurred in the clip group

4 per 1000

1 per 1000

(0 to 28)

Minor morbidity: total

Low risk population

OR 2.15

(1.22 to 3.78)

842
(2)

⊕⊕⊕⊕
high

57 per 1000

123 per 1000
(70 to 215)

Minor morbidity: details ‐ procedure‐related injuries

Low risk population

OR 1.95

(1.36 to 2.78)

3575
(3)

⊕⊕⊕⊕
high

21 per 1000

41 per 1000
(29 to 58)

Technical failures

Low risk population

OR 3.93

(2.43 to 6.35)

3476

(3)

⊕⊕⊕⊕
high

10 per 1000

39 per 1000
(24 to 63)

Failure rate: details

(12 to 24 months)

Low risk population

OR 0.72

(0.33 to 1.57)

3822
(4)

⊕⊕⊕⊕
high

4 per 1000

3 per 1000
(1 to 6)

Complaints: Postoperative pain

(24 hours)

Low risk population

OR 1.14

(0.88 to 1.48)

922

(3)

⊕⊕⊕⊕
high

477 per 1000

544 per 1000
(420 to 706)

*The basis for the assumed risk is the median control group (clip) risk across studies. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; OR: odds ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Downgraded due to imprecision.

2 Downgraded due to sparse data.

Figuras y tablas -
Summary of findings for the main comparison. Summary of findings: ring versus clip
Summary of findings 2. Summary of findings: modified Pomeroy partial salpingectomy versus electrocoagulation

Modified Pomeroy partial salpingectomy compared with tubal electrocoagulation for interval sterilisation

Patient or population: women > 6 weeks postpartum requesting tubal sterilisation

Settings: any

Intervention: modified Pomeroy partial salpingectomy

Comparison: electrocoagulation

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Electrocoagulation

Modified Pomeroy

Major morbidity: total

Low risk population

OR 2.87

(1.13 to 7.25)

1905

(2)

⊕⊕⊝⊝
low1,2

10 per 1000

29 per 1000
(11 to 73)

Major morbidity: procedure‐related injuries requiring additional operation or blood transfusion

10 per 1000

19 per 1000

(19 to 190)

OR 1.90

(0.19 to 18.96)

1905

(2)

⊕⊕⊝⊝
low 1,2

Major morbidity: rehospitalisation as a consequence of the operation

20 per 1000

115 per 1000

(15 to 900)

OR 5.74

(0.73 to 45.09)

295

(1)

⊕⊝⊝⊝
very low1,2

Minor morbidity: total

Low risk population

OR 1.60

(1.10 to 2.33)

1905

(2)

⊕⊕⊝⊝
low 1,4

The WHO study reported significantly more wound infections in the modified Pomeroy group, where participants underwent minilaparotomy, compared with the electrocoagulation group where laparoscopy was used)

38 per 1000

61 per 1000
(42 to 89)

Minor morbidity: procedure‐related injuries with no additional operation

Low risk population

OR 0.53

(0.06 to 5.11)

1610
(1)

⊕⊕⊕⊝
moderate1

2 per 1000

1 per 1000
0 to 10)

Failure rate: total

(12 months)

Low risk population

OR 4.47 (0.07 to 286.78)

295

(1)

⊕⊕⊝⊝
low1,3

0.5 per 1000

2 per 1000

(0 to 143)

Complaints ‐ postoperative pain

(24 hours)

Low risk population

OR 3.85

(2.91 to 5.10)

1905

(2)

⊕⊕⊕⊝
moderate4

95 per 1000

366 per 1000
(276 to 485)

Complaints ‐ persistent pain at follow‐up visit

Low risk population

OR 1.09

(0.88 to 1.47)

1610
(1)

⊕⊕⊕⊝
moderate4

117 per 1000

128 per 1000
(95 to 172)

*The basis for the assumed risk is the median control group (electrocoagulation) risk across studies. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; OR: odds ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Downgraded due to imprecision.

2 Downgraded due to inconsistency.

3 Sparse data.

4 Downgraded due to indirectness (this effect may be due to the abdominal approach (minilaparotomy versus laparoscopy) rather than the tubal technique).

Figuras y tablas -
Summary of findings 2. Summary of findings: modified Pomeroy partial salpingectomy versus electrocoagulation
Summary of findings 3. Summary of findings: tubal ring versus electrocoagulation

Tubal ring compared with electrocoagulation for interval sterilisation

Patient or population: women > 6 weeks postpartum requesting tubal sterilisation

Settings: any

Intervention: tubal ring

Comparison: electrocoagulation

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Electrocoagulation

Ring

Major morbidity: total

Low risk population

OR 0.14

0.00 to 7.01

596
(2)

⊕⊕⊝⊝

low1,2

Unipolar electrocoagulation stated in one study and not specified in the other. Only one event reported in total

0.5 per 1000

0 per 1000

(0 to 4)

Minor morbidity: total

Low risk population

OR 0.97

(0.50, 1.87)

596
(2)

⊕⊕⊕⊝
moderate1

66 per 1000

64 per 1000
(33 to 123)

Technical failures: total

Low risk population

OR 3.42

(0.59 to 19.81)

596
(2)

⊕⊕⊕⊝
moderate1

3 per 1000

10 per 1000
(2 to 60)

Failure rate: total

not estimable

not estimable

Not estimable due to insufficient data

160
(1)

No pregnancies reported in one study

Complaints ‐ postoperative pain

(24 hours)

Low risk population

OR 3.40

(1.17 to 9.84)

596
(2)

⊕⊕⊝⊝

low1,3

176 per 1000

598 per 1000
(206 to 1000)

Complaints ‐ persistent pain at follow‐up visit

Low risk population

OR 1.22

(0.75 to 1.97)

594
(2)

⊕⊕⊕⊝
moderate1

140 per 1000

171 per 1000
(105 to 276)

*The basis for the assumed risk is the median control group (electrocoagulation) risk across studies. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; OR: odds ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Downgraded due to imprecision.

2 Downgraded due to sparse data.

3 Downgraded due to inconsistency.

Figuras y tablas -
Summary of findings 3. Summary of findings: tubal ring versus electrocoagulation
Summary of findings 4. Summary of findings: partial salpingectomy versus clip

Partial salpingectomy compared with tubal clips for tubal sterilisation

Patient or population: women requesting postpartum or interval sterilisation

Settings: any

Intervention: partial salpingectomy

Comparison: tubal clips

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Clips

Partial salpingectomy

Major morbidity: total

Low risk population

not estimable

2198
(1)

No deaths or major morbidity events reported in one large trial

0 per 1000

0 per 1000

Minor morbidity: total

Low risk population

OR 7.39

(0.46 to 119.01)

193
(1)

⊕⊕⊝⊝
low1,2

0.5 per 1000

4 per 1000
(0 to 60)

Technical failures

Low risk population

OR 0.18

(0.08 to 0.40)

2198
(1)

⊕⊕⊕⊝
moderate3

20 per 1000

4 per 1000
(2 to 8)

Failure rate: total

(12 months)

Low risk population

OR 0.21, 95% CI 0.05 to 0.84

3537
(2)

⊕⊕⊕⊝
moderate 4

In this analysis, we grouped studies according to whether sterilisation was performed on a postpartum (1) or interval basis (1). Results were similar across these subgroups (Test for subgroup differences: P value 0.58, I² = 0%)

2 per 1000

0.4 per 1000
(0 to 2)

Complaints

(12 months)

Low risk population

OR 1.30 (0.92 to 1.82)

2137

(1)

⊕⊕⊕⊝
moderate1

This single study reported data on 'chief complaints' at 3, 6, and 12 months and rates were similar between groups at all assessment points

59 per 1000

77 per 1000

(54 to 107)

*The basis for the assumed risk is the median control group (clips) risk across studies. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; OR: odds ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Downgraded due to imprecision.

2 Downgraded due to sparse data.

3 Downgraded due to indirectness (unclear whether silver clips and Filshie clips are similarly effective).

4 Downgraded due to risk of bias.

Figuras y tablas -
Summary of findings 4. Summary of findings: partial salpingectomy versus clip
Summary of findings 5. Summary of findings: Hulka clip versus Filshie clip

Hulka clips compared with Filshie clips for interval sterilisation

Patient or population: women requesting sterilisation

Settings: any

Intervention: Hulka clips

Comparison: Filshie clips

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Filshie clip

Hulka clip

Minor morbidity: total

Low risk population

OR 0.14

(0.00 to 7.32)

197
(1)

⊕⊕⊝⊝
low1,2

10 per 1000

1 per 1000
(0 to 70)

Minor morbidity: procedure‐related injuries

Low risk population

OR 1.55

(0.73 to 3.26)

2322
(2)

⊕⊕⊕⊝
moderate1

10 per 1000

16 per 1000
(7 to 33)

Technical failures

Low risk population

OR 1.04

(0.10 to 11.33)

2325

(2)

⊕⊕⊝⊝
low1,3

7 per 1000

7 per 1000

(1 to 79)

Failure rate: total

(12 months)

Low risk population

OR 6.20

(0.75 to 51.66)

1441

(1)

⊕⊕⊕⊝
moderate1

1 per 1000

6 per 1000

(1 to 52)

Complaints: postoperative pain

(24 hours)

Low risk population

OR 1.74

(0.99 to 3.03)

197
(1)

⊕⊕⊝⊝
low1,4

45 per 1000

78 per 1000
(45 to 136)

*The basis for the assumed risk is the median control group (Filshie clips) risk across studies. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; OR: odds ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Downgraded due to imprecision.

2 Downgraded due to sparse data.

3Downgraded due to inconsistency.

4 Downgraded due to risk of bias.

Figuras y tablas -
Summary of findings 5. Summary of findings: Hulka clip versus Filshie clip
Comparison 1. Tubal ring versus clip

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Major morbidity: total Show forest plot

1

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

1.1 Procedure‐related injuries requiring additional operation or blood transfusion

1

545

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.14 [0.00, 7.05]

2 Minor morbidity: total Show forest plot

2

842

Peto Odds Ratio (Peto, Fixed, 95% CI)

2.15 [1.22, 3.78]

3 Minor morbidity: details Show forest plot

3

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

3.1 Procedure related injuries with no additional operation

3

3575

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.95 [1.36, 2.78]

3.2 Urogenital infections

3

3145

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.88 [0.83, 4.28]

3.3 Wound infection

3

3144

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.17 [0.73, 1.87]

3.4 Postoperative temperature > 38 °C without hospitalisation

1

296

Peto Odds Ratio (Peto, Fixed, 95% CI)

7.49 [0.15, 377.52]

4 Technical failures Show forest plot

3

3476

Peto Odds Ratio (Peto, Fixed, 95% CI)

3.93 [2.43, 6.35]

5 Technical difficulties Show forest plot

3

3590

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.13 [0.87, 1.46]

6 Failure rate: total Show forest plot

4

3822

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.72 [0.33, 1.57]

7 Failure rate: details Show forest plot

2

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

7.1 Failure rate ≤ 1 year, total

2

2629

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.85 [0.23, 3.14]

7.2 Failure rate ≤ 1 year, extrauterine pregnancy

1

2202

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.0 [0.0, 0.0]

7.3 Failure rate > 1 year, extrauterine pregnancy

1

427

Peto Odds Ratio (Peto, Fixed, 95% CI)

8.11 [0.16, 410.33]

8 Operative time Show forest plot

1

297

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

9 Hospital stay > 24 h Show forest plot

1

Odds Ratio (M‐H, Fixed, 95% CI)

Totals not selected

10 Complaints Show forest plot

4

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

10.1 Postoperative pain < 24 h

3

922

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.14 [0.88, 1.48]

10.2 Postoperative analgesic use

1

70

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.70 [0.28, 1.79]

10.3 Cramping pain during first week after surgery

1

70

Peto Odds Ratio (Peto, Fixed, 95% CI)

5.24 [1.52, 18.00]

11 Menstrual irregularities Show forest plot

2

612

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.61 [0.75, 3.49]

Figuras y tablas -
Comparison 1. Tubal ring versus clip
Comparison 2. Partial salpingectomy (modified Pomeroy) versus electrocoagulation

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Operative mortality Show forest plot

1

1610

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.0 [0.0, 0.0]

2 Major morbidity: total Show forest plot

2

1905

Peto Odds Ratio (Peto, Fixed, 95% CI)

2.87 [1.13, 7.25]

3 Major morbidity: details Show forest plot

2

Odds Ratio (M‐H, Random, 95% CI)

Subtotals only

3.1 Procedure‐related injuries requiring additional operation or blood transfusion

2

1905

Odds Ratio (M‐H, Random, 95% CI)

1.90 [0.19, 18.96]

3.2 Rehospitalisation as a consequence of operation

1

295

Odds Ratio (M‐H, Random, 95% CI)

5.74 [0.73, 45.09]

4 Minor morbidity: total Show forest plot

2

1905

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.60 [1.10, 2.33]

5 Minor morbidity: details Show forest plot

2

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

5.1 Procedure‐related injuries with no additional operation

1

1610

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.53 [0.06, 5.11]

5.2 Urogenital infections

1

1610

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.81 [0.43, 1.50]

5.3 Wound infection

1

1610

Peto Odds Ratio (Peto, Fixed, 95% CI)

2.49 [1.54, 4.04]

5.4 Postoperative temperature > 38 °C without hospitalisation

1

295

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.45 [0.18, 11.77]

6 Failure rate: total Show forest plot

1

295

Peto Odds Ratio (Peto, Fixed, 95% CI)

4.47 [0.07, 286.78]

6.1 Failure rate, total

1

295

Peto Odds Ratio (Peto, Fixed, 95% CI)

4.47 [0.07, 286.78]

7 Failure rate: details Show forest plot

1

295

Peto Odds Ratio (Peto, Fixed, 95% CI)

4.47 [0.07, 286.78]

7.1 Failure rate > 1 year, total

1

295

Peto Odds Ratio (Peto, Fixed, 95% CI)

4.47 [0.07, 286.78]

8 Hospital stay more 24 h Show forest plot

1

108

Odds Ratio (M‐H, Fixed, 95% CI)

0.48 [0.08, 2.74]

9 Complaints Show forest plot

3

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

9.1 Postoperative pain < 24 h

2

1905

Peto Odds Ratio (Peto, Fixed, 95% CI)

3.85 [2.91, 5.10]

9.2 Postoperative analgesic use

1

109

Peto Odds Ratio (Peto, Fixed, 95% CI)

2.05 [0.40, 10.56]

9.3 Persistent pain at follow‐up visit

1

1610

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.09 [0.81, 1.47]

Figuras y tablas -
Comparison 2. Partial salpingectomy (modified Pomeroy) versus electrocoagulation
Comparison 3. Tubal ring versus electrocoagulation

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Major morbidity: total Show forest plot

2

596

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.14 [0.00, 7.01]

2 Major morbidity: details Show forest plot

1

298

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.14 [0.00, 7.01]

2.1 Procedure‐related injuries requiring additional operation or blood transfusion

1

298

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.14 [0.00, 7.01]

3 Minor morbidity: total Show forest plot

2

596

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.97 [0.50, 1.87]

4 Minor morbidity: details Show forest plot

2

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

4.1 Procedure‐related injuries with no additional operation

2

596

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.76 [0.17, 3.38]

4.2 Urogenital infections

1

296

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.03 [0.14, 7.37]

4.3 Wound infection

1

296

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.93 [0.38, 2.25]

4.4 Postoperative temperature > 38 °C without hospitalisation

2

594

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.37 [0.31, 6.06]

5 Technical failures: total Show forest plot

2

596

Peto Odds Ratio (Peto, Fixed, 95% CI)

3.42 [0.59, 19.81]

6 Technical difficulties Show forest plot

1

298

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.14 [0.01, 1.33]

7 Failure rate: total Show forest plot

1

160

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.0 [0.0, 0.0]

7.1 Failure rate, total

1

160

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.0 [0.0, 0.0]

8 Operative time Show forest plot

1

298

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

9 Complaints Show forest plot

2

Odds Ratio (M‐H, Random, 95% CI)

Subtotals only

9.1 Postoperative pain < 24 h

2

596

Odds Ratio (M‐H, Random, 95% CI)

3.40 [1.17, 9.84]

9.2 Postoperative analgesic use

1

298

Odds Ratio (M‐H, Random, 95% CI)

2.51 [1.00, 6.30]

9.3 Persistent pain at follow‐up visit

2

594

Odds Ratio (M‐H, Random, 95% CI)

1.22 [0.75, 1.97]

10 Menstrual irregularities Show forest plot

1

296

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.90 [0.56, 1.45]

Figuras y tablas -
Comparison 3. Tubal ring versus electrocoagulation
Comparison 4. Partial salpingectomy (PS) versus clip

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Operative mortality Show forest plot

1

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

1.1 Uchida vs silver clip

1

2198

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.0 [0.0, 0.0]

2 Major morbidity: total Show forest plot

1

2198

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.0 [0.0, 0.0]

2.1 Uchida vs silver clip

1

2198

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.0 [0.0, 0.0]

3 Minor morbidity: total Show forest plot

1

193

Peto Odds Ratio (Peto, Fixed, 95% CI)

7.39 [0.46, 119.01]

4 Minor morbidity: details Show forest plot

1

193

Peto Odds Ratio (Peto, Fixed, 95% CI)

7.39 [0.46, 119.01]

4.1 Procedure related injuries with no additional operation

1

193

Peto Odds Ratio (Peto, Fixed, 95% CI)

7.39 [0.46, 119.01]

5 Technical failures Show forest plot

1

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

5.1 Uchida vs silver clip

1

2198

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.18 [0.08, 0.40]

6 Technical difficulties Show forest plot

1

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

6.1 Uchida vs silver clip

1

2198

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.97 [0.42, 2.24]

7 Failure rate (12 months) : total Show forest plot

2

3537

Odds Ratio (M‐H, Random, 95% CI)

0.21 [0.05, 0.84]

7.1 Pomeroy vs Filshie

1

1400

Odds Ratio (M‐H, Random, 95% CI)

0.22 [0.05, 1.02]

7.2 Uchida vs silver clip

1

2137

Odds Ratio (M‐H, Random, 95% CI)

0.19 [0.01, 3.95]

8 Operative time Show forest plot

2

2223

Mean Difference (IV, Fixed, 95% CI)

4.26 [3.65, 4.86]

8.1 Pomeroy vs Filshie

1

25

Mean Difference (IV, Fixed, 95% CI)

6.70 [0.77, 12.63]

8.2 Uchida vs silver clip

1

2198

Mean Difference (IV, Fixed, 95% CI)

4.23 [3.62, 4.84]

9 All complaints Show forest plot

1

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

9.1 Uchida vs silver clip

1

2137

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.30 [0.92, 1.82]

10 Menstrual irregularities Show forest plot

2

2283

Odds Ratio (M‐H, Random, 95% CI)

1.43 [0.73, 2.79]

10.1 Pomeroy vs Filshie

1

146

Odds Ratio (M‐H, Random, 95% CI)

2.49 [0.88, 7.05]

10.2 Uchida vs silver clip

1

2137

Odds Ratio (M‐H, Random, 95% CI)

1.16 [0.90, 1.49]

11 Women's satisfaction Show forest plot

1

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

11.1 Uchida vs silver clip

1

2110

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.27 [0.99, 1.64]

12 Surgeon's satisfaction Show forest plot

Other data

No numeric data

Figuras y tablas -
Comparison 4. Partial salpingectomy (PS) versus clip
Comparison 5. Hulka versus Filshie clip

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Minor morbidity: total Show forest plot

1

197

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.14 [0.00, 7.32]

2 Minor morbidity: details Show forest plot

2

Odds Ratio (M‐H, Random, 95% CI)

Subtotals only

2.1 Procedure‐related injuries with no additional operation

2

2322

Odds Ratio (M‐H, Random, 95% CI)

1.57 [0.73, 3.36]

2.2 Urogenital infection

1

1910

Odds Ratio (M‐H, Random, 95% CI)

2.40 [0.62, 9.30]

2.3 Wound complications

1

1910

Odds Ratio (M‐H, Random, 95% CI)

0.86 [0.63, 1.17]

3 Technical failures Show forest plot

2

2325

Odds Ratio (M‐H, Random, 95% CI)

1.04 [0.10, 11.33]

4 Technical difficulties Show forest plot

2

2323

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.51 [1.09, 2.10]

5 Failure rate: total Show forest plot

1

1441

Odds Ratio (M‐H, Fixed, 95% CI)

6.20 [0.75, 51.66]

6 Operative time Show forest plot

1

197

Mean Difference (IV, Fixed, 95% CI)

0.70 [‐0.04, 1.44]

7 Complaints Show forest plot

1

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

7.1 Postoperative pain < 24 h

1

197

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.74 [0.99, 3.03]

Figuras y tablas -
Comparison 5. Hulka versus Filshie clip